Literature DB >> 18359432

Nebulized imipenem to control nosocomial pneumonia caused by Pseudomonas aeruginosa.

M Radhakrishnan, A Jaganath, G S Umamaheswara Rao, H B Veena Kumari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18359432     DOI： 10.1016/j.jcrc.2007.10.037

Source DB:  PubMed          Journal:  J Crit Care        ISSN： 0883-9441            Impact factor:   3.425


× No keyword cloud information.
  4 in total

Review 1.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

2.  Use of inhaled imipenem/cilastatin in pediatric patients with cystic fibrosis: A case series.

Authors:  Lee Ann Jones; Lorna Doucette; Elisabeth P Dellon; Charles R Esther; Cameron J McKinzie
Journal:  J Cyst Fibros       Date:  2019-05-03       Impact factor: 5.482

3.  Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species.

Authors:  Angus M Quinn; Michael J Bottery; Harry Thompson; Ville-Petri Friman
Journal:  ISME J       Date:  2022-07-20       Impact factor: 11.217

Review 4.  Pulmonary infections complicating ARDS.

Authors:  Charles-Edouard Luyt; Lila Bouadma; Andrew Conway Morris; Jayesh A Dhanani; Marin Kollef; Jeffrey Lipman; Ignacio Martin-Loeches; Saad Nseir; Otavio T Ranzani; Antoine Roquilly; Matthieu Schmidt; Antoni Torres; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2020-11-11       Impact factor: 17.440
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.